AI assistant
PFIZER INC — Director's Dealing 2024
Feb 27, 2024
29831_dirs_2024-02-27_8e930e62-2917-4b03-9e7d-4acdb0df16a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2024-02-23
Reporting Person: BOURLA ALBERT (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-23 | Common Stock | M | 127674.0000 | $27.3400 | Acquired | 439748.0000 | Direct |
| 2024-02-23 | Common Stock | F | 8831.0000 | $27.7600 | Disposed | 430917.0000 | Direct |
| 2024-02-23 | Common Stock | F | 103178.0000 | $27.3700 | Disposed | 327739.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | Stock Appreciation Rights | $27.3400 | M | 127674.0000 | Disposed | 2024-02-23 | Common Stock (127674.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4750.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.